- NCIt
- C116915
Loading cancer entity…
Loading cancer entity…
Clinical trials
47 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06296368 | DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics(DISCOVERY) | recruiting | N/A | 500 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Aug 14, 2026 | clinicaltrials |
| NCT03654404 | A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients | completed | N/A | 29 | Brigham and Women's HospitalOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT05391490 | Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies(KCAT19) | recruiting | Phase 1 | 12 | University College, LondonOTHER | 1 | Aug 11, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Aug 14, 2026source: clinicaltrials
| NCT06469307 |
| Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)(DIVERSE) |
| recruiting |
| N/A |
| 40 |
| Dana-Farber Cancer InstituteOTHER |
| 1 |
| Jul 16, 2026 |
| clinicaltrials |
| NCT06482515 | Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue | recruiting | Phase 2 | 96 | University of Maryland, BaltimoreOTHER | 1 | Jun 5, 2026 | clinicaltrials |
| NCT07052916 | A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties | recruiting | N/A | 60 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT05646576 | Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy(PEACE) | recruiting | N/A | 90 | Massachusetts General HospitalOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT06510699 | Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial(PRAGMATIC) | recruiting | Phase 2 | 104 | The University of QueenslandOTHER | 2 | Apr 16, 2026 | clinicaltrials |
| NCT05873205 | Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation | active not recruiting | Phase 2 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT07148180 | A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax | recruiting | Phase 1 / Phase 2 | 31 | Jacqueline Garcia, MDOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07305090 | Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut(GUT-PREDICTION) | recruiting | — | 90 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT06116032 | Immune Profiling for Cancer Immunotherapy Response | recruiting | — | 1,500 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT06455592 | Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years(APANYX) | recruiting | N/A | 30 | University Hospital, Clermont-FerrandOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT04188678 | Resiliency in Older Adults Undergoing Bone Marrow Transplant(REBOUND) | completed | — | 126 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 27, 2025 | clinicaltrials |
| NCT05450367 | Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.(PRONOSTIM) | completed | — | 249 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06582849 | Enhanced Assistance During Radiotherapy for Unmet Essential Needs(EARN) | completed | N/A | 33 | Washington University School of MedicineOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT01166009 | CIBMTR Research Database | recruiting | — | 99,999,999 | Center for International Blood and Marrow Transplant ResearchNETWORK | 1 | Aug 12, 2025 | clinicaltrials |
| NCT07058571 | Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention | recruiting | N/A | 30 | VA Pittsburgh Healthcare SystemFED | 1 | Jul 10, 2025 | clinicaltrials |
| NCT06119685 | IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers | recruiting | Phase 1 / Phase 2 | 128 | Indapta Therapeutics, INC.INDUSTRY | 1 | Jun 3, 2025 | clinicaltrials |
| NCT06168825 | Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention(MOM) | completed | — | 40 | Inova Health Care ServicesOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06645132 | Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant. | active not recruiting | N/A | 15 | Medical College of WisconsinOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06817759 | Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer | not yet recruiting | N/A | 60 | Ciusss de L'Est de l'Île de MontréalOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT04466059 | Better Leukemia Diagnostics Through AI (BELUGA)(BELUGA) | recruiting | — | 25,000 | Munich Leukemia LaboratoryINDUSTRY | 1 | Dec 17, 2024 | clinicaltrials |
| NCT06543511 | MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies | withdrawn | N/A | 0 | Dana-Farber Cancer InstituteOTHER | 0 | Nov 22, 2024 | clinicaltrials |
| NCT04737785 | Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation | completed | — | 252 | European Society for Blood and Marrow TransplantationNETWORK | 12 | Aug 27, 2024 | clinicaltrials |
| NCT06574308 | Clinical Evaluation of the Scopio Cell Morphology Technology(Hemascopio) | unknown | — | 300 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT04955938 | A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms | withdrawn | Phase 1 | 0 | University of ChicagoOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05190653 | Early Integration of Palliative and Supportive Care in Cellular Therapy(PALS_CT) | unknown | N/A | 152 | Alberta Health Services, CalgaryOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05147311 | Positive Psychology Intervention In HSCT(PATH-3) | completed | N/A | 72 | Brigham and Women's HospitalOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT03959046 | GIST in Hematopoietic Stem Cell Transplantation/Bone Marrow Transplantation | withdrawn | N/A | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT06250595 | European Rare Blood Disorders Platform (ENROL)(ENROL) | recruiting | — | 37,090 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 1 | Feb 9, 2024 | clinicaltrials |
| NCT05692713 | Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201) | unknown | — | 320 | University of British ColumbiaOTHER | 2 | Dec 8, 2023 | clinicaltrials |
| NCT04372524 | Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study | unknown | — | 350 | University of British ColumbiaOTHER | 2 | Dec 5, 2023 | clinicaltrials |
| NCT05709522 | Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients(PBT) | unknown | — | 80 | Aga Khan UniversityOTHER | 1 | Feb 2, 2023 | clinicaltrials |
| NCT02361346 | Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL(MT-3724NHL001) | terminated | Phase 1 / Phase 2 | 38 | Molecular Templates, Inc.INDUSTRY | 10 | Aug 18, 2022 | clinicaltrials |
| NCT04806295 | The Leukemia and Lymphoma Society (LLS) National Research Registry | recruiting | — | 1,000 | Blood Cancer UnitedOTHER | 1 | Apr 7, 2022 | clinicaltrials |
| NCT04390542 | Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy | withdrawn | N/A | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jul 20, 2021 | clinicaltrials |
| NCT00185640 | Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies | completed | Phase 2 | 303 | Stanford UniversityOTHER | 1 | Jun 29, 2021 | clinicaltrials |
| NCT04419623 | A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer | completed | Phase 1 | 7 | Telios Pharma, Inc.INDUSTRY | 1 | May 12, 2021 | clinicaltrials |
| NCT04236063 | Rehabilitation Needs of the Malaysian Haematological Cancer Survivors | completed | — | 168 | University of MalayaOTHER | 1 | Nov 4, 2020 | clinicaltrials |
| NCT00186225 | Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors | completed | N/A | 250 | Stanford UniversityOTHER | 1 | Apr 9, 2020 | clinicaltrials |
| NCT00185692 | Allogeneic Transplantation From Related Haploidentical Donors | completed | Phase 2 | 16 | Stanford UniversityOTHER | 1 | Dec 4, 2019 | clinicaltrials |
| NCT00185614 | Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma | completed | Phase 2 | 63 | Wen-Kai WengOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT01957579 | A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies | completed | Phase 1 | 32 | AstraZenecaINDUSTRY | 1 | Jun 12, 2017 | clinicaltrials |
| NCT00185796 | TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD | completed | Phase 2 | 77 | Stanford UniversityOTHER | 1 | Mar 18, 2015 | clinicaltrials |
| NCT00962494 | Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors | completed | Phase 2 | 585 | Stanford UniversityOTHER | 2 | Feb 7, 2013 | clinicaltrials |
| NCT00230321 | A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS) | completed | Phase 1 / Phase 2 | 21 | Peter L GreenbergOTHER | 1 | Feb 4, 2013 | clinicaltrials |